Lansaol Yang

[Lansaol Yang @LansaolY]

These past two years have felt like a dream to me. I can't express how grateful I am for the opportunity to have worked in this department, surrounded by such bright and inspiring people who have all taught me so much. I especially want to thank Dr. Lubelski for his mentorship and unwavering support, which have helped me grow in so many ways and shaped me into the person I am today.

I also want to thank everyone I have had the chance to work with. Each of you is incredibly unique and talented, and I have learned something from every one of you.

I wish you all the very best moving forward. I know that you will all get to where you want to be and - let's stay in touch!

[The S.P.I.N.E. Oncology Innovation Lab @LubelskiLab]

🎉A huge congratulations to Lansaol Yang @LansaolY, our stellar clinical researcher, as she heads west to begin a PhD in Molecular Pharmacology at University of California, Los Angeles!!

During her two years at Johns Hopkins, Lansaol has taken on an extraordinary range of work, from pushing forward more than 20 projects and leading lab meetings with over 15 teammates, to scaling multi-institutional studies across the country and everything in between. She has a special way of bringing people together through her positive energy and warm personality. We’re honored to have had her with us and have learned so much from her caring and determined leadership.

UCLA is lucky to get such an all-star. Stay in touch, Lansaol! We're all proud of you and excited to see what you spearhead next!✨

@DanielLubelski @HopkinsSpine @UCLAGradSchool

[The S.P.I.N.E. Oncology Innovation Lab @LubelskiLab]

🔔Congratulations to our team on our latest publication in Neurosurgery!

As immunotherapy becomes a central component of cancer care, an important question emerges:
💭Can immunotherapy be safely continued in the perioperative setting for patients with spinal metastases?

In a cohort of 367 patients undergoing surgery for spinal metastases, we observed that perioperative immunotherapy use was not associated with increased wound complications or greater severity of wound-related outcomes. Multivariable analysis similarly showed no independent effect on wound healing (OR 0.40, 95% CI 0.09-1.69).

🔗 Full-text link:
https://t.co/SeeRrJZOkR

📌Takehome: Despite ongoing concerns regarding immune modulation and wound repair, these findings suggest no clinically meaningful negative impact of perioperative immunotherapy on wound healing.

@NeurosurgeryCNS @HopkinsSpine @HopkinsNsurg

#Neurosurgery #Spine #SpineSurgery #Oncology #Immunotherapy

[The S.P.I.N.E. Oncology Innovation Lab @LubelskiLab]

A proud moment for our lab member, Lansaol Yang, who presented the study “Trauma across pediatric ages: age stratified epidemiology, injury patterns, and outcomes in pediatric cervical spinal cord injury. A National Trauma Registry analysis” at CSRS 2025.

The work provides important insight into the injury epidemiology, treatment patterns, and clinical outcomes of pediatric patients with traumatic cervical spinal cord injury.

Grateful for the hard work and support from our team, and thankful to the CSRS community for the warm welcome!
@CSRS_org @DanielLubelski @DrNTheodore @LansaolY @abdul_ghaith
#CSRS2025 #Neurosurgery #Trauma #CervicalSpine

[Abdul Karim Ghaith,MD,PhD @abdul_ghaith]

This year, we submitted a record-breaking 115 abstracts to the CNS meeting @CNS_Update and the results are in:
🎤 23 Oral Presentations
📌 30 Printed Posters
💻 62 Digital Posters

From AI and machine learning to big data analytics, basic science, and breakthrough ultrasound research, we’re proud to be at the forefront of innovation in spine and neurosurgery.

Deepest thanks to my incredible mentors @DrNTheodore, @DanielLubelski @LubelskiLab @AManbachi whose unwavering support, vision, and mentorship made this journey possible. @HopkinsSpine @HopkinsNsurg @LansaolY @TahaKhalilullah @AJDavidson_1

🌟 Let’s make some noise in Los Angeles. See you there!
#CNS2025 #Neurosurgery #SpineInnovation #AIinMedicine #Ultrasound #Gratitude #Teamwork

[Abdul Karim Ghaith,MD,PhD @abdul_ghaith]

We conducted the largest NCDB analysis comparing spinal chordoma vs. chondrosarcoma, integrating machine learning to personalize survival prediction.

We developed a web-based survival calculator for individualized prognostication.

Huge thanks to my mentors Dr. Nicholas Theodore and Dr. Daniel Lubelski!
@DrNTheodore @LubelskiLab @DanielLubelski @LansaolY

#Neurosurgery #SpineTumor #Chordoma #Chondrosarcoma #RadiationOncology #MachineLearning #PersonalizedMedicine #AIinMedicine #MedTwitter

[Lansaol Yang @LansaolY]

@JrWillBeGr8 LMAOOoooo